应用转录组和外显子组测序分析不同年龄组的胶质母细胞瘤中基因表达与突变的差异

王志刚 刘伟

解剖学报 ›› 2019, Vol. 50 ›› Issue (1) : 8-12.

PDF(6853 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(6853 KB)
解剖学报 ›› 2019, Vol. 50 ›› Issue (1) : 8-12. DOI: 10.16098/j.issn.0529-1356.2019.01.002
神经生物学

应用转录组和外显子组测序分析不同年龄组的胶质母细胞瘤中基因表达与突变的差异

  • 王志刚1 刘伟2*
作者信息 +

Analysis of the difference in gene expression and mutation of glioblastoma in different age groups by using the transcriptional and exome sequencing

  • WANG Zhi-gang1 LIU Wei 2*
Author information +
文章历史 +

摘要

目的 探讨通过转录组和外显子组测序分析不同年龄组的胶质母细胞瘤的差异。 方法 多形性胶质母细胞瘤(GBM)数据下载自TCGA项目。将样本分为2组,不高于60岁的样本为中低年龄组,共78例;高于60岁的样本为高年龄组,共76例。使用R语言DESeq2软件包对RNA-seq原始基因水平的reads数目数据进行差异表达分析。使用Cytoscape插件ClueGO进行不同年龄组别差异表达基因功能富集分析。 结果 GBM致病基因在两组之间大部分基因表达趋势一致,但存在差异基因。在中低龄组中差异基因主要和神经前体细胞增殖相关,而高年龄组偏重于代谢方面。在两组中高突变的基因有很多重叠。样本突变率不同的基因主要为中低年龄组特有,且具有高样本突变率的基因。 结论 中低年龄组和高龄组GBM患者在基因表达和基因突变上存在明显差异。

Abstract

Objective To explore the gene expression difference of glioblastoma in different age groups through the sequencing of the transcriptome and exome. Methods Glioblastoma multiforme(GBM) data was downloaded from the Cancer Genome Atlas(TCGA), and the samples were divided into two groups. There were 78 cases in the middle and low age group not more than 60 years old, compared with the high age group of 60 years old, with a total of 76 cases. DESeq2 package was used to analyze differentially expressed genes based on gene level reads numbers. Cytoscape plug-in ClueGO was used to analyze gene function enrichment in different age groups. Results Most of the gene expression trends in the two groups were consistent between the two groups, but there were some different genes. In the middle and low age group, the differential gene was mainly related to the proliferation of neural precursor cells, while the high age group was metabolic. In the two groups, the high mutation genes were basically consistent, but the mutation rates were different. The mutation differentially genes were concentrated in the middle and low age groups. Conclusion There is a significant difference in gene expression and gene mutation between the middle and low age group and the elderly GBM group.

关键词

转录组测序 / 年龄 / 胶质母细胞瘤 / 全外显子组测序 /

Key words

RNA-sequencing / Age;Glioblastoma / Exome-sequencing / Human

引用本文

导出引用
王志刚 刘伟. 应用转录组和外显子组测序分析不同年龄组的胶质母细胞瘤中基因表达与突变的差异[J]. 解剖学报. 2019, 50(1): 8-12 https://doi.org/10.16098/j.issn.0529-1356.2019.01.002
WANG Zhi-gang LIU Wei. Analysis of the difference in gene expression and mutation of glioblastoma in different age groups by using the transcriptional and exome sequencing[J]. Acta Anatomica Sinica. 2019, 50(1): 8-12 https://doi.org/10.16098/j.issn.0529-1356.2019.01.002

参考文献

 [1]Young RM, Jamshidi A,Davis G,et al. Current trends in the surgical management and treatment of adult glioblastoma[J]. Ann Transl Med, 2015, 3(9): 121.
 [2]Lorimer CF, Hanna C, Saran F, et al. Challenges to treating older glioblastoma patients: the influence of clinical and tumour characteristics on survival outcomes [J]. Clin Oncol (R Coll Radiol), 2017,29(11): 739-747.
 [3]Hartmann C, Hentschel B, Wick W, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas [J]. Acta Neuropathol, 2010, 120(6): 707-718.
 [4]Nobusawa S, Watanabe T, Kleihues P, et al. DH1 mutations as molecular signature and predictive factor of secondary glioblastomas[J]. Clin Cancer Res, 2009, 15(19): 6002-6007.
 [5]Love MI, Huber W, Anders S. Anders. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2[J]. Genome Biol, 2014, 15(12): 550.
 [6]Filimon A, Zurac SA, Milac AL, et al. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors[J]. Melanoma Res, 2014, 24(3): 219-236.
 [7]Wang K, Chen D, Qian Z, et al. Hedgehog/Gli1 signaling pathway regulates MGMT expression and chemoresistance to temozolomide in human glioblastoma[J]. Cancer Cell Int, 2017,17(117):1-12.
 [8]Tong Y, Xu Y, Scearce-Levie K, et al. COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo[J]. Neurogenetics, 2010, 11(1): 41-52.
 [9]Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation[J]. Nature, 2008, 455(7216): 1129-1133.
 [10]Han B, Cai J, Gao W, et al. Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma[J]. Cancer Lett, 2018, 419: 280-290.
 [11]Russo A, O’Bryan JP. Intersectin 1 is required for neuroblastoma tumorigenesis[J]. Oncogene, 2012, 31(46): 4828-4834.

PDF(6853 KB)

Accesses

Citation

Detail

段落导航
相关文章

/